| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |